Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-03

Clinical Trial Update: Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating glucagon rescue of insulin-induced hypoglycemia in adults with Type 1 diabetes treated with volagidemab has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)
  • volagidemab (volagidemab)

Snippet

Sponsor: REMD Biotherapeutics, Inc. | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED